tradingkey.logo
tradingkey.logo
Suchen

Enovis Corp

ENOV
Zur Watchlist hinzufügen
21.700USD
+1.660+8.28%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.25BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Enovis Corp Unternehmen

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp Informationen

BörsenkürzelENOV
Name des UnternehmensEnovis Corp
IPO-datumMay 08, 2008
CEOMcdonald (Damien)
Anzahl der mitarbeiter7367
WertpapierartOrdinary Share
GeschäftsjahresendeMay 08
Addresse2711 Centerville Road
StadtWILMINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19808
Telefon13022529160
Websitehttps://www.enovis.com/
BörsenkürzelENOV
IPO-datumMay 08, 2008
CEOMcdonald (Damien)

Führungskräfte von Enovis Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Enovis Corp?

Die fünf größten Anteilseigner von Enovis Corp sind: Mr. Daniel Alexis Pryor

Wie viele Institutionen halten Anteile an Enovis Corp (ENOV)?

Mit Stand vom 2026Q1 halten 652 Institutionen Anteile an Enovis Corp, mit einem Gesamtmarktwert von etwa 68.97M, was 119.81% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -6763998.00 gestiegen.

Was ist die größte Einnahmequelle von Enovis Corp?

Am 2026Q1 erzielte das Geschäft mit Medical Technology-Prevention & Rehabilitation für Enovis Corp den höchsten Umsatz in Höhe von 1.14B, was 50.58% des Gesamtumsatzes entspricht.